← All companies

SANA

Sana Biotechnology, Inc.

SANA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.40

+0.22 +6.92%

Key statistics

from XBRL data in SEC filings

Market cap

$946M

Revenue (TTM)

—

Net income (TTM)

-$242M

EPS (TTM)

$-0.92

P/E ratio

—

Dividend yield

—

Free cash flow

-$145M

Cash

$83.8M

Total assets

$374M

Gross margin

—

52-week range

$2.61 – $6.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 5, 2026 8-K Other events May 15, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Director or officer change Apr 24, 2026 8-K Other events Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release); Other events Mar 3, 2026 8-K Director or officer change; Regulation FD disclosure Feb 17, 2026 8-K Regulation FD disclosure Jan 14, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Other events Sep 5, 2025 8-K Director or officer change Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Entered a material agreement; Other events Aug 7, 2025 8-K Results of operations (earnings release); Other events Aug 6, 2025 8-K Other events Jun 23, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Other events May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release) Mar 17, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release) Nov 8, 2024 8-K Director or officer change Oct 8, 2024 8-K Director or officer change Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change Apr 18, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Entered a material agreement; Other events Feb 8, 2024 8-K Results of operations (earnings release); Other events Feb 7, 2024 8-K Regulation FD disclosure Jan 9, 2024